Alexion Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
ALXN
CUSIP
015351109
All holders as of
Q4 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q4 1 193 $5.40 k
2025 Q3 1 193 $5.79 k
2025 Q2 1 193 $5.52 k
2024 Q4 1 6.94 k $924 k
2023 Q4 1 61.0 $8.83 k
2023 Q3 1 61.0 $10.4 k
2023 Q2 1 61.0 $13.6 k
2023 Q1 1 61.0 $13.0 k
2022 Q4 1 61.0 $13.0 k
2022 Q3 1 61.0 $16.0 k
2022 Q2 1 60.0 $13.0 k
2022 Q1 1 60.0 $13.0 k
2021 Q4 2 86.0 $14.0 k
2021 Q3 7 5.80 k $845 k
2021 Q2 740 212 M $39.1 B
2021 Q1 795 205 M $31.3 B
2020 Q4 885 202 M $31.7 B
2020 Q3 769 200 M $22.8 B
2020 Q2 757 201 M $22.5 B
2020 Q1 729 202 M $18.1 B
2019 Q4 731 207 M $22.4 B
2019 Q3 715 208 M $20.4 B
2019 Q2 704 214 M $28.2 B
2019 Q1 674 216 M $29.2 B
2018 Q4 662 215 M $20.9 B
2018 Q3 644 220 M $30.6 B
2018 Q2 657 214 M $26.5 B
2018 Q1 660 212 M $23.6 B
2017 Q4 649 212 M $25.3 B
2017 Q3 650 214 M $30.1 B
2017 Q2 613 214 M $26.0 B
2017 Q1 608 215 M $26.0 B
2016 Q4 607 220 M $26.9 B
2016 Q3 561 217 M $26.6 B
2016 Q2 587 218 M $25.4 B
2016 Q1 561 226 M $30.5 B
2015 Q4 591 225 M $42.9 B
2015 Q3 554 225 M $35.1 B
2015 Q2 598 220 M $39.8 B
2015 Q1 605 193 M $33.5 B
2014 Q4 612 194 M $35.9 B
2014 Q3 560 192 M $33.5 B
2014 Q2 557 194 M $30.4 B
2014 Q1 531 191 M $29.0 B